Leucinamide hydrochloride → N-[N-(3,4-dichlorophenyl)-L-alanyl]-L-leucine amide

HRID 1870319

반응식

HRID 1870319 반응식
Cl.[NH2:2][C@H:3]([C:8]([NH2:10])=[O:9])[CH2:4][CH:5]([CH3:7])[CH3:6].[Cl:11][C:12]1[CH:13]=[C:14]([NH:19][CH:20]([C:22](O)=[O:23])[CH3:21])[CH:15]=[CH:16][C:17]=1[Cl:18]>>[Cl:11][C:12]1[CH:13]=[C:14]([NH:19][C@H:20]([C:22]([NH:10][C:8](=[O:9])[C@H:3]([CH2:4][CH:5]([CH3:7])[CH3:6])[NH2:2])=[O:23])[CH3:21])[CH:15]=[CH:16][C:17]=1[Cl:18]

참가 물질

3

실험 절차

Following General Procedure D and using L-leucinamide hydrochloride (Sigma) and N-(3,4-dichlorophenyl)-D,L-alanine (from Example A above), the title compound was prepared. This compound was then purified by column chromatography, eluted first with 1:1 EtOAc/hexane, then with 5% MeOH) in methylene chloride.

후처리

  1. customThis compound was then purified by column chromatography
  2. washeluted first with 1:1 EtOAc/hexane

출처 및 근거

ORD 기록
ord-b8ba0db84f4a4fdf8bf30aec586ad325
출처 데이터셋
uspto-grants-2000_08
특허 번호
US06096782

연결된 노트

불러오는 중…